Literature DB >> 21852330

Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea.

A Barceló1, J Piérola, M de la Peña, C Esquinas, M Sanchez-de la Torre, O Ayllón, A Alonso, A G N Agusti, F Barbè.   

Abstract

Patients with sleep apnoea have a significant alteration in the day-night pattern of myocardial infarction and sudden cardiac death observed in the general population. The aim of this study was to investigate the influence of sleep apnoea on the diurnal variations in various haemostatic parameters (factor VII, von Willebrand factor and plasminogen activator inhibitor (PAI)-1) and markers of endothelial dysfunction (asymmetric dimethylarginine (ADMA) and soluble CD40 ligand (sCD40L)). We studied 26 male patients with obstructive sleep apnoea syndrome (OSAS; 13 patients with severe OSAS (apnoea/hypopnoea index (AHI) >30 events · h(-1)) and 13 patients with mild-to-moderate OSAS (AHI <30 events · h(-1))) and 12 controls of similar body mass index (BMI) and waist circumference. In each subject, six different samples were obtained over 24 h. Although all the markers values tended to be higher in patients with severe OSAS, differences did not reach statistical significance at any time. PAI-1 levels were significantly related to BMI (p<0.001), mean (p<0.001) and minimal (p = 0.047) nocturnal oxygenation saturation. ADMA levels were significantly related to arousal index (p = 0.046). The results of this study suggest that day-night variations in factor VII:antigen (Ag), von Willebrand factor:Ag, PAI-1, sCD40L and ADMA levels may be dependent on either the obesity index or metabolic dysfunction rather than on sleep apnoea alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852330     DOI: 10.1183/09031936.00039911

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Sleep, death, and the heart.

Authors:  Meghna P Mansukhani; Shihan Wang; Virend K Somers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

2.  The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study.

Authors:  Zehra Tosur; David Green; Peter John De Chavez; Kristen L Knutson; Jeffrey J Goldberger; Phyllis Zee; Kiang Liu; Kwang-Youn Kim; Mercedes R Carnethon
Journal:  Sleep Med       Date:  2014-04-30       Impact factor: 3.492

Review 3.  Obstructive Sleep Apnea and Smoking as a Risk Factor for Venous Thromboembolism Events: Review of the Literature on the Common Pathophysiological Mechanisms.

Authors:  Eric Deflandre; Stephanie Degey; Natacha Opsomer; Jean-Francois Brichant; Jean Joris
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

Review 4.  Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.

Authors:  Domenico Maurizio Toraldo; Michele De Benedetto; Egeria Scoditti; Francesco De Nuccio
Journal:  Sleep Breath       Date:  2015-07-14       Impact factor: 2.816

5.  Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; Tanya Wolfson; Anthony C Gamst; José S Loredo; Joel E Dimsdale
Journal:  Sleep Med       Date:  2012-10-01       Impact factor: 3.492

Review 6.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

Review 7.  Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.

Authors:  Mohammad Badran; Saeid Golbidi; Najib Ayas; Ismail Laher
Journal:  Sleep Disord       Date:  2015-05-06

8.  Postoperative vascular complications in unrecognised Obstructive Sleep apnoea (POSA) study protocol: an observational cohort study in moderate-to-high risk patients undergoing non-cardiac surgery.

Authors:  Matthew T V Chan; Chew-Yin Wang; Edwin Seet; Stanley Tam; Hou-Yee Lai; Stuart Walker; Timothy G Short; Richard Halliwell; Frances Chung
Journal:  BMJ Open       Date:  2014-01-09       Impact factor: 2.692

Review 9.  Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction-Molecular Mechanisms and Clinical Significance.

Authors:  Juliane Hannemann; Rainer Böger
Journal:  Front Med (Lausanne)       Date:  2022-02-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.